An update on vulvovaginal candidiasis (thrush)

MeReC Bulletin

Volumn 14, Issue 4, 2003, Pages 13-16

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; BORIC ACID; CLOTRIMAZOLE; CORTICOSTEROID; ECONAZOLE; FENTICONAZOLE; FLUCONAZOLE; FLUCYTOSINE; IMIDAZOLE; IMIDAZOLE DERIVATIVE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; NON PRESCRIPTION DRUG; NYSTATIN; ORAL CONTRACEPTIVE AGENT; POVIDONE IODINE; PROBIOTIC AGENT; SUGAR; TEA TREE OIL;

ALLERGIC REACTION; ARTICLE; CANDIDA ALBICANS; CLINICAL TRIAL; CLOTHING; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DISEASE CLASSIFICATION; DOSE RESPONSE; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; EVIDENCE BASED MEDICINE; FEMALE; FUNGUS CULTURE; GENERAL PRACTITIONER; HEALTH BEHAVIOR; HEALTH PRACTITIONER; HEPATITIS; HUMAN; IMMUNE DEFICIENCY; MEDICAL LITERATURE; PATIENT ATTITUDE; PATIENT EDUCATION; PATIENT REFERRAL; PREGNANCY; PRESCRIPTION; PSYCHOSEXUAL DISORDER; RECTUM; RECURRENT INFECTION; SEXUALITY; SUGAR INTAKE; TAMPON; TREATMENT PLANNING; VAGINA CANDIDIASIS; VAGINA DISCHARGE; VAGINITIS;

EID: 1442300938     PISSN: 14655659     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Sobel JD. Genital candidosis. Medicine 2001;29:67-71.
2. Denning DW. Fortnightly review: management of genital candidiasis (working group of the British Society for Medical Mycology). BMJ 1995;310:1241-4.
3. Nwokolo NC, Boag FC. Chronic vaginal candidiasis: management in the postmenopausal patient. Drugs Aging 2000;16:335-9.
4. Donders GGG, Prenen H, Verbeke G, et al. Impaired tolerance for glucose in women with recurrent vaginal candidiasis. Gynecol 2002;187:989-93.
5. Young GL, Jewell D. Topical treatment for vaginal candidiasis (thrush) in pregnancy (Cochrane Review). In: The Cochrane Library, Issue 1, 2004. Chichester, UK: John Wiley & Sons, Ltd.
6. Prodigy (2001) Candida - female genital. Sowerby Centre for Health Informatics at Newcastle. Available from: URL: http://www.prodigy.nhs.uk
7. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). National guideline for the management of vulvovaginal candidiasis. Sex Transm Inf 1999;75:S19-S20.
8. Scharbo-DeHaan M, Anderson DG. The CDC 2002 guidelines for the treatment of sexually transmitted disease: implications for women's health care. J Midwifery Womens Health 2003;48:96-104.
9. British National Formulary. No 46. London: British Medical Association/Royal Pharmaceutical Society of Great Britain; 2003.
10. Bingham JS. What to do with the patient with recurrent vulvovaginal candidiasis. Sex Transm Inf 1999;75:225-7.
11. Marrazzo J. Candidiasis (vulvovaginal). In: Godlee F, editor. Clinical evidence. 9th ed. London: BMJ Publishing Group; 2003. p. 1980-94.
12. Watson MC, Grimshaw JM, Bond CM, Mollison J, Ludbrook A. Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush). (Cochrane Review). In: The Cochrane Library, Issue 1, 2004. Chichester, UK: John Wiley & Sons, Ltd.
13. Diflucan One. Summary of product characteristics. Available from: URL: http://www.medicines.org.uk/.
14. Sporanox. Summary of product characteristics. Availablefrom: URL: http://www.medicines.org.uk/.
15. Nizoral. Summary of product characteristics. Available from: URL: http://www.medicines.org.uk/.
16. Mårdh PA, Rodrigues AG, Mehmet G, et al. Facts and myths on recurrent vulvoginal candidosis - a review of epidemiology, clinical manifestations, diagnosis, pathogenesis and therapy. Int J STDs AIDS 2002:13:522-39.
17. Ferris DG, Nyirjesy P, Sobel J, et al. Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis. Obstet Gynecol 2002;99:419-25.
18. Sihvo S, Ahonen R, Mikander H, et al. Self-medication with vaginal antifungal drugs: physicians' experiences and women's utilization patterns. Fam Pract 2000;17:145-9.
19. Canestan Once. Summary of product characteristics. Available from: URL: http://www.medicines.org.uk/.
20. Communicable disease surveillance centre: England and Wales. Antimicrobial resistance in 2000. London: Public Health Laboratory Service. Available from: URL: http://www.hpa.org.uk. Accessed 23/1/04.
21. Sobel JD, Zervos M, Reed BD, et al. Fluconazole susceptibility of vaginal isolates obtained from women with complicated Candida vaginits: clinical implications. Antimicrob Agents Chemother 2003;47:34-8.